STL Made Galera Therapeutics’ Stock Rises Following Positive Study for Experimental Cancer Therapy
May 11, 2021
Biopharmaceutical company Galera Therapeutics‘ stock price rose 41% after showing results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company is […]
Read More
Innovative Tenant Spotlight
January 29, 2020
MediBeacon, a St. Louis-based biotech company with a focus on commercializing devices and optical agents for use in diagnostics, has been a tenant of the […]
Read More